MedPath

宿州亿帆药业有限公司

Ownership
-
Established
2013-03-21
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

133

NMPA:133

Drug Approvals

Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution

Product Name
氨溴特罗口服溶液
Approval Number
国药准字H20253562
Approval Date
Mar 4, 2025
NMPA

Diazoxide Oral Suspension

Product Name
二氮嗪口服混悬液
Approval Number
国药准字H20243049
Approval Date
Jan 9, 2024
NMPA

Podophyllotoxin Ointment

Product Name
鬼臼毒素软膏
Approval Number
国药准字H20083643
Approval Date
Dec 12, 2023
NMPA

Ketoconazole Cream

Product Name
酮康唑乳膏
Approval Number
国药准字H20184073
Approval Date
May 11, 2023
NMPA

Diclofenac Sodium Cream

Product Name
双氯芬酸钠乳膏
Approval Number
国药准字H20184074
Approval Date
Apr 28, 2023
NMPA

妇阴康洗剂

Approval Number
国药准字Z20123050
Approval Date
Apr 7, 2022
NMPA

Hydrogen Peroxide Solution

Product Name
过氧化氢溶液
Approval Number
国药准字H34021560
Approval Date
Mar 14, 2022
NMPA

清凉油

Approval Number
国药准字Z34020246
Approval Date
Mar 14, 2022
NMPA

普乐安片

Approval Number
国药准字Z34021056
Approval Date
Jan 26, 2022
NMPA

Urea Cream

Product Name
尿素乳膏
Approval Number
国药准字H20173056
Approval Date
Dec 22, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 14
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.